HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John D. Miller Lyall A. Gorenstein Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, J. D. Articles by Patterson, G. A. Search for Related Content PubMed PubMed Citation Articles by Miller, J. D. Articles by Patterson, G. A.

Ann Thorac Surg 1992;53:170-178
© 1992 The Society of Thoracic Surgeons

---

Articles

Staging: The key to rational management of lung cancer

Division of Thoracic Surgery, Department of Surgery, Toronto Hospital, Toronto General Division, University of Toronto, Toronto, Ontario, Canada

^_* Address reprint requests to Dr Patterson, Division of Cardiothoracic Surgery, Washington University School of Medicine, 1 Barnes Hospital Plaza, Suite 3108, St. Louis, MO 63110.

Staging is the quantitative assessment of malignant disease and allows logical groupings of patients with a similar extent of disease for prognostic, therapeutic, and analytic purposes. In bronchogenic carcinoma a stage is assigned based on size, location, and the extent of invasion of the primary tumor, as well as the presence of any regional or metastatic disease. Selecting the most appropriate treatment for a patient with bronchogenic carcinoma depends on precise staging. The extent of local invasion and presence of metastatic disease will determine the likelihood of complete resection and possible cure. Careful assessment of the history, blood chemistry, radiographic studies, bronchoscopy, mediastinoscopy, and exploration (thoracotomy) are all important staging tools. Routine radionuclide scans have no useful role when there is no clinical or laboratory evidence of metastases. The T status of a tumor is best judged by bronchoscopy and at thoracotomy. Thoracic surgeons must be familiar with the techniques available to determine T status intraoperatively and use this information when planning resection. Computed tomography of the chest has fallen short in predicting direct invasion of the mediastinum and chest wall. Cervical and anterior mediastinoscopy remain important tools in determining operability. Intraoperative assessment of node involvement determines the extent of resection and likelihood of cure.

This article has been cited by other articles:

				L. A. Mandell Lower respiratory tract infections: when are antibiotics mandatory? Thoracic Malignancies, June 28, 2010; 146 - 164. [Abstract] [Fulltext] [PDF]

				M. B. Wallace, M. I. Block, W. Gillanders, J. Ravenel, B. J. Hoffman, C. E. Reed, M. Fraig, D. Cole, and M. Mitas Accurate Molecular Detection of Non-small Cell Lung Cancer Metastases in Mediastinal Lymph Nodes Sampled by Endoscopic Ultrasound-Guided Needle Aspiration Chest, February 1, 2005; 127(2): 430 - 437. [Abstract] [Full Text] [PDF]

				M. B. Wallace, J. Ravenel, M. I. Block, M. Fraig, G. Silvestri, S. Wildi, N. Schmulewitz, S. Varadarajulu, S. Roberts, B. J. Hoffman, et al. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography Ann. Thorac. Surg., May 1, 2004; 77(5): 1763 - 1768. [Abstract] [Full Text] [PDF]

				H. Akay, A. K. Cangir, H. Kutlay, S. Kavukcu, I. Okten, and S. Yavuzer Surgical treatment of peripheral lung cancer adherent to the parietal pleura Eur J Cardiothorac Surg, October 1, 2002; 22(4): 615 - 620. [Abstract] [Full Text] [PDF]

				M. J. Liptay, S. C. Grondin, W. A. Fry, C. Pozdol, D. Carson, C. Knop, G. A. Masters, R. M. Perlman, and W. Watkin Intraoperative Sentinel Lymph Node Mapping in Non-Small-Cell Lung Cancer Improves Detection of Micrometastases J. Clin. Oncol., April 15, 2002; 20(8): 1984 - 1988. [Abstract] [Full Text] [PDF]

				G J M Herder, P Verboom, E F Smit, P C M van Velthoven, J H A M van den Bergh, C D Colder, I van Mansom, J C van Mourik, P E Postmus, G J J Teule, et al. Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals Thorax, January 1, 2002; 57(1): 11 - 14. [Abstract] [Full Text] [PDF]

				R. Komaki, M. H. Chasen, W. D. Travis, J. B. Putnam, F. V. Fossella, R. W. Byhardt, and J. Y. Ro Oncodiagnosis Panel: 1999: Cancer of the Lung: Oncodiagnosis RadioGraphics, November 1, 2001; 21(6): 1573 - 1596. [Full Text] [PDF]

				T. Niki, S. Iba, M. Tokunou, T. Yamada, Y. Matsuno, and S. Hirohashi Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma Clin. Cancer Res., June 1, 2000; 6(6): 2431 - 2439. [Abstract] [Full Text]

				J. Deslauriers and J. Gregoire Clinical and Surgical Staging of Non-Small Cell Lung Cancer Chest, April 1, 2000; 117(2009): 96S - 103S. [Abstract] [Full Text] [PDF]

				A. P.C. Yim, R. J. Landreneau, M. B. Izzat, A. L.K. Fung, and S. Wan Is video-assisted thoracoscopic lobectomy a unified approach? Ann. Thorac. Surg., October 1, 1998; 66(4): 1155 - 1158. [Abstract] [Full Text] [PDF]

				T. Funatsu, Y. Matsubara, S. Ikeda, R. Hatakenaka, T. Hanawa, and H. Ishida Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 321 - 328. [Abstract] [Full Text]

				J. C. Wain Video-assisted thoracoscopy and the staging of lung cancer Ann. Thorac. Surg., September 1, 1993; 56(3): 776 - 778. [Abstract] [PDF]

				J. S. Chambers Better salvage in non-small cell lung cancer Ann. Thorac. Surg., August 1, 1992; 54(2): 399 - 400. [PDF]